Suppr超能文献

Merkel 细胞多瘤病毒大 T 抗原 C 端缺失,一种用于病毒诱导恶性肿瘤的高度特异性替代标志物。

C-terminal deletions of Merkel cell polyomavirus large T-antigen, a highly specific surrogate marker for virally induced malignancy.

机构信息

Research Program Infection and Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

出版信息

Int J Cancer. 2012 Dec 15;131(12):2863-8. doi: 10.1002/ijc.27607. Epub 2012 Jun 26.

Abstract

In 67-100% of cutaneous Merkel cell carcinomas (MCC) the Merkel cell polyomavirus (MCPyV) integrates into the host genome. Mutations and deletions truncating the C-terminal helicase domain of the T-antigen (TAg) protein have been detected in these MCCs, but not in healthy skin specimens. C-terminal deletions of the TAg nucleic acid sequences are characteristic for about 38% of these cases. While the association of MCPyV with MCC has been proven, it is unknown whether MCPyV may play a similar role in other tumor entities. We describe in detail the development and validation of a novel Merkel cell polyomavirus TAg C-terminus deletion assay (MCPyV ΔC-TAg). The triplex real-time PCR quantifies the N- and C-terminal part of the MCPyV TAg gene and the cellular β-globin gene. By comparing the copy numbers of the N- and C-terminal part, deletions of the MCPyV TAg C-terminus are rapidly identified. MCPyV ΔC-TAg was used to assess the physical state of MCPyV TAg in a large series of 55 MCCs, 15 cutaneous lymphomas and 47 forehead smears of healthy individuals. Neither DNA positivity nor viral load was able to discriminate MCCs from the other different types of samples. However, deleted TAg C-terminus sequences were detected only in MCPyV positive MCCs (39%). Consequently, detection of deleted C-terminal TAg sequences appears to be a highly specific surrogate marker for virally induced malignancy and should be used to support novel assumed MCPyV-tumor associations. The study further supports the notion that MCPyV does not play a role in cutaneous lymphoma pathogenesis.

摘要

在 67%-100%的皮肤 Merkel 细胞癌 (MCC) 中,Merkel 细胞多瘤病毒 (MCPyV) 会整合到宿主基因组中。在这些 MCC 中已经检测到了截断 T 抗原 (TAg) 蛋白 C 末端解旋酶结构域的突变和缺失,但在健康皮肤标本中没有检测到。TAg 核酸序列的 C 末端缺失在这些病例中约占 38%。虽然已经证明 MCPyV 与 MCC 有关,但尚不清楚 MCPyV 是否可能在其他肿瘤实体中发挥类似作用。我们详细描述了一种新型 Merkel 细胞多瘤病毒 TAg C 末端缺失检测 (MCPyV ΔC-TAg) 的开发和验证。三重实时 PCR 定量检测 MCPyV TAg 基因的 N 和 C 末端以及细胞β-球蛋白基因。通过比较 N 和 C 末端的拷贝数,可以快速识别 MCPyV TAg C 末端的缺失。MCPyV ΔC-TAg 用于评估 55 例 MCC、15 例皮肤淋巴瘤和 47 例健康个体额部涂片的大量 MCPyV TAg 物理状态。DNA 阳性或病毒载量均不能区分 MCC 与其他不同类型的样本。然而,仅在 MCPyV 阳性的 MCC 中检测到缺失的 TAg C 末端序列 (39%)。因此,检测缺失的 C 末端 TAg 序列似乎是一种高度特异性的病毒诱导恶性肿瘤替代标志物,应用于支持新假设的 MCPyV-肿瘤关联。该研究进一步支持了 MCPyV 不会在皮肤淋巴瘤发病机制中发挥作用的观点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验